The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...
The UK’s aspiration to be a global leader in life science and health technologies is one backed up by world-class research and innovation. Yet the pathway from medical technology conception to patient ...
This is not what NHS data shows. Around 6.5 million people are waiting for 7.8 million courses of treatment in England, according to the latest figures, because some are waiting for more than one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results